Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis.
ApoTransferrin: Dual Role on Adult Subventricular Zone-Derived Neurospheres.
Uveitis as a prognostic factor in multiple sclerosis.
Treatment of NMO relapse in the elderly: rituximab when plasma exchange fails?
Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).
Cannabis-based medicines in multiple sclerosis--a review of clinical studies.
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis.
Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
Treatment of Acute Disseminated Encephalomyelitis.
Daclizumab for relapsing remitting multiple sclerosis.
Regulation of claudins in blood-tissue barriers under physiological and pathological states.
Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial.
Bilateral idiopathic optic neuritis in pregnancy.
Efficient transdifferentiation of human adipose-derived stem cells into Schwann-like cells: A promise for treatment of demyelinating diseases.
2-BFI ameliorates EAE-induced mouse spinal cord damage: Effective therapeutic time window and possible mechanisms.
Active Biotech's partner Teva initiates a laquinimod clinical trial in Huntington's disease
The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude.
A case of acute disseminated encephalomyelitis associated with hepatitis C virus infection.
Functional plasticity in MS: Friend or foe?
Role of IL-16 in CD4(+) T cell-mediated regulation of relapsing multiple sclerosis.
Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis.
Biomarkers of treatment response in multiple sclerosis.
Vitamin D status and the risk of multiple sclerosis: A systematic review and meta-analysis.
The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans.
Vitamin D and multiple sclerosis: what is the clinical impact?
Pages
« first
‹ previous
…
211
212
213
214
215
216
217
218
219
…
next ›
last »